The objective of this study is to evaluate objective changes in water content, sebum content,
transepidermal water loss (TEWL), and melanin due to breast cancer chemotherapy, and …

Chemotherapy and its cutaneous side effects are an increasingly common source of
iatrogenic injury to the skin, hair, and nails. Cutaneous changes are among the most …

BACKGROUND: Internal malignancies such as breast cancer, as well as their treatment can
often result in skin changes. OBJECTIVE: To assess the prevalence of dermatological …

O tratamento local e sistêmico das neoplasias pode causar alterações na pele, membranas
mucosas, cabelos e unhas. O diagnóstico preciso eo tratamento adequado destes efeitos …

Median PFS in patients who were observed with rash during the treatment was 3.0 vs. 1.2
months in patients with no rash (p< 0.001), median of OS in patients who were observed …

Introduction The purpose of this multicenter, prospective, observational, open-label study
was to evaluate the use and tolerability of dermo-cosmetic products in preventing skin …

Objective Sorafenib is one of the few standard agents for metastatic renal cell carcinoma.
Although sorafenib-induced erythema multiforme is rarely reported, we evaluated the cases …

abstract Cutaneous adverse drug reactions (CADR) represent a heterogeneous field
including various clinical patterns without specific features suggesting drug causality …

The new molecular targeted therapy has been developed over the past decades by using
the molecular targeted molecular changes discovered in specific types of cancer …

Multikinase inhibitors (MKIs, eg, sorafenib and sunitinib) are oral anticancer agents
associated with hand-foot skin reaction (HFSR), a cutaneous adverse event affecting 20 …